Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review
- PMID: 36329343
- PMCID: PMC10042904
- DOI: 10.1007/s15010-022-01943-3
Updated diagnosis and graft involvement for visceral leishmaniasis in kidney transplant recipients: a case report and literature review
Abstract
Purpose: Visceral leishmaniasis (VL) has become a rising concern to transplantation teams, being associated with graft dysfunction and reduced survival of renal transplant recipients. Here, we describe a case of VL occurring in a kidney transplant (KT) recipient in Italy, a country in which Leishmania infantum is endemic and we reviewed the literature on the clinical course and diagnosis of VL in KT recipients residing or travelling to southern Europe.
Results: The VL case was diagnosed 18 months after transplant and 28 days after the onset of symptoms by quantitative PCR (qPCR) on peripheral blood. A graft biopsy showed renal involvement, and PCR performed on graft tissue displayed the presence of Leishmania DNA. The retrospective confirmation of Leishmania-positive serology in a serum sample collected before transplantation, as well as the absence of anti-Leishmania IgG in the graft donor strongly suggest that reactivation of a latent parasitic infection caused VL in the current case.
Conclusion: VL is often underdiagnosed in transplant recipients, despite the presence of latent Leishmania infection being reported in endemic countries. This case report, as well as the literature review on leishmaniasis in KT recipients, underline the importance of rapid VL diagnosis to promptly undergo treatment. Serology is scarcely sensitive in immunocompromised patients, thus molecular tests in peripheral blood should be implemented and standardized for both VL identification and follow-up.
Keywords: Infection; Kidney; Leishmania; Transplantation.
© 2022. The Author(s).
Conflict of interest statement
All other authors declare that they have no relevant financial interests.
Figures

References
-
- Gradoni L, López-Vélez R, Mokni M. Manual on case management and surveillance of the leishmaniases in the WHO European Region. Geneva: World Health Organization; 2017.
-
- La Hoz RM, Morris MI, Transplantation IDCOPOTASO Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients. Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:13546. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical